CoreValve Evolut Pro Prospective Registry
NCT03423459 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2023-05-26
Summary
The primary objective of this study is to evaluate the real-world performance of the CoreValve Evolut PRO transcatheter aortic valve, including leaflet function, in a prospective observational registry.
Conditions
- Aortic Stenosis
Interventions
- DEVICE
-
TAVR
Transcatheter Aortic Valve Replacement
Sponsors & Collaborators
-
Medtronic Cardiovascular
collaborator INDUSTRY -
Medstar Health Research Institute
lead OTHER
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-18
- Primary Completion
- 2023-12-31
- Completion
- 2024-12-31
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
The Medtronic CoreValve™ Evolut R™ CE Mark Clinical Study
NCT01876420 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
NCT01586910 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis
NCT02628899 ·Status: COMPLETED ·Phase: NA
-
CoreValve Advance International Post Market Study
NCT01074658 ·Status: COMPLETED
-
The TransCatheter Valve and Vessels Trial
NCT03424941 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement
NCT01531374 ·Status: COMPLETED ·Phase: NA
-
The Bicuspid Aortic Stenosis Following Transcatheter Aortic Valve Replacement Registry
NCT02394184 ·Status: COMPLETED
-
Optimize PRO Study
NCT04091048 ·Status: COMPLETED
-
Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement
NCT01675440 ·Status: COMPLETED
-
Transcatheter Aortic Prosthesis Function: A Long-term Follow-up Study
NCT03002272 ·Status: RECRUITING
-
accuRate Evaluation of Benefit With Optimal Medical Treatment With or Without Transcatheter Valve Repair of PARADOXical Low Flow Low Gradient Aortic Stenosis
NCT03863132 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients
NCT02701283 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Assessment of TRanscathetEr and Surgical Aortic BiOprosthetic Valve Thrombosis and Its TrEatment With Anticoagulation
NCT02318342 ·Status: RECRUITING ·Phase: NA
-
TAVI in Intermediate Risk Septuagenarians With Risk Factors Not Captured by the Traditional Surgical Risk Scores
NCT04517955 ·Status: UNKNOWN
-
Long-term Prognosis and Valve Durability of TAVR
NCT06379386 ·Status: RECRUITING
-
Early neo2 Registry of the Acurate neo2 TAVI Prosthesis
NCT04810195 ·Status: COMPLETED
-
A Registry to Evaluate the Direct Flow Medical Transcatheter Aortic Valve System
NCT01845285 ·Status: UNKNOWN
-
Behavior of Valve Leaflets Following Aortic Valve Implant
NCT03200574 ·Status: COMPLETED ·Phase: NA
-
Added Value of Patient-specific Computer Simulation in Transcatheter Aortic Valve Implantation (TAVI)
NCT03196596 ·Status: COMPLETED
-
PRospective Evaluation Complementing Investigation With Acurate Neo Device
NCT03846557 ·Status: COMPLETED
-
DEFLECT I: Keystone Heart Embolic Deflection Trial
NCT01448421 ·Status: COMPLETED ·Phase: NA
-
ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement
NCT03735667 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis
NCT06212050 ·Status: ENROLLING_BY_INVITATION
-
Evaluation of Effectiveness and Safety of Evolut R Valve In Patients With Pure Aortic Regurgitation
NCT03578952 ·Status: TERMINATED ·Phase: NA
-
Transcatheter Aortic Valve Replacement (TAVR) Effects on Cardiac Conduction System
NCT04982406 ·Status: COMPLETED